Company · CIK 1635077
Aclarion, Inc.
| CIK | 1635077 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 8071 — Services-Medical Laboratories |
| Incorporated in | DE |
| Business address | CO |
| Listed | ACON (Nasdaq), ACONW (Nasdaq) |
| First annual or quarterly report | 2022-06-06 |
Offerings
10 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-286761 | 2025-04-25 | 2026-01-09 | 4 | |
| 333-281999 | 2024-09-09 | 2025-01-31 | 5 | |
| 333-283724 | 2024-12-11 | 2025-01-16 | 5 | |
| 333-282970 | 2024-11-04 | 2024-11-08 | 2 | |
| 333-282842 | 2024-10-25 | 2024-11-04 | 2 | |
| 333-276648 | 2024-01-22 | 2024-10-24 | 4 | |
| 333-275989 | 2023-12-11 | 2024-02-27 | 6 | |
| 333-274914 | 2023-10-10 | 2023-10-20 | 3 | |
| 333-273113 | 2023-07-03 | 2023-07-14 | 3 | |
| 333-262026 | 2022-01-06 | 2022-04-25 | 8 |
Filings
43| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-01-09 | 424B5Shelf takedown | 333-286761 | 0001683168-26-000166 |
| 2025-10-14 | 424B5Shelf takedown | 333-286761 | 0001683168-25-007514 |
| 2025-05-05 | EFFECTDeclared effective | 333-286761 | 9999999995-25-001425 |
| 2025-04-25 | S-3Shelf registered | 333-286761 | 0001683168-25-002839 |
| 2025-01-31 | 424B5Shelf takedown | 333-281999 | 0001683168-25-000625 |
| 2025-01-16 | 424B4Final prospectus | 333-283724 | 0001683168-25-000389 |
| 2025-01-14 | EFFECTDeclared effective | 333-283724 | 9999999995-25-000103 |
| 2025-01-10 | S-1/AAmendment | 333-283724 | 0001683168-25-000233 |
| 2025-01-06 | 424B5Shelf takedown | 333-281999 | 0001683168-25-000098 |
| 2024-12-26 | S-1/AAmendment | 333-283724 | 0001683168-24-008988 |
| 2024-12-11 | S-1Registration filed | 333-283724 | 0001683168-24-008624 |
| 2024-11-08 | EFFECTDeclared effective | 333-282970 | 9999999995-24-003437 |
| 2024-11-04 | EFFECTDeclared effective | 333-282842 | 9999999995-24-003369 |
| 2024-11-04 | S-3Shelf registered | 333-282970 | 0001683168-24-007558 |
| 2024-10-25 | S-1Registration filed | 333-282842 | 0001683168-24-007397 |
| 2024-10-24 | EFFECTDeclared effective | 333-276648 | 9999999995-24-003260 |
| 2024-09-24 | 424B5Shelf takedown | 333-281999 | 0001683168-24-006625 |
| 2024-09-23 | EFFECTDeclared effective | 333-281999 | 9999999995-24-002931 |
| 2024-09-09 | S-3Shelf registered | 333-281999 | 0001683168-24-006247 |
| 2024-02-27 | 424B4Final prospectus | 333-275989 | 0001683168-24-001189 |
| 2024-02-26 | EFFECTDeclared effective | 333-275989 | 9999999995-24-000543 |
| 2024-02-23 | S-1/AAmendment | 333-275989 | 0001683168-24-001147 |
| 2024-02-21 | S-1/AAmendment | 333-275989 | 0001683168-24-001095 |
| 2024-02-06 | S-1/AAmendment | 333-275989 | 0001683168-24-000730 |
| 2024-02-01 | EFFECTDeclared effective | 333-276648 | 9999999995-24-000288 |
| 2024-01-31 | S-1/AAmendment | 333-276648 | 0001683168-24-000585 |
| 2024-01-22 | S-1Registration filed | 333-276648 | 0001683168-24-000371 |
| 2023-12-11 | S-1Registration filed | 333-275989 | 0001683168-23-008784 |
| 2023-10-20 | EFFECTDeclared effective | 333-274914 | 9999999995-23-003043 |
| 2023-10-20 | S-1/AAmendment | 333-274914 | 0001683168-23-007308 |
| 2023-10-10 | S-1Registration filed | 333-274914 | 0001683168-23-007031 |
| 2023-07-14 | EFFECTDeclared effective | 333-273113 | 9999999995-23-002098 |
| 2023-07-12 | S-1/AAmendment | 333-273113 | 0001683168-23-004813 |
| 2023-07-03 | S-1Registration filed | 333-273113 | 0001683168-23-004614 |
| 2022-04-25 | 424B4Final prospectus | 333-262026 | 0001683168-22-002903 |
| 2022-04-21 | EFFECTDeclared effective | 333-262026 | 9999999995-22-001046 |
| 2022-04-20 | S-1/AAmendment | 333-262026 | 0001683168-22-002814 |
| 2022-04-19 | S-1/AAmendment | 333-262026 | 0001683168-22-002795 |
| 2022-04-01 | S-1/AAmendment | 333-262026 | 0001683168-22-002267 |
| 2022-03-23 | S-1/AAmendment | 333-262026 | 0001683168-22-001851 |
| 2022-03-04 | S-1/AAmendment | 333-262026 | 0001683168-22-001434 |
| 2022-01-06 | S-1Registration filed | 333-262026 | 0001683168-22-000097 |
| 2021-10-25 | DRSDraft made public | 377-05621 | 0001683168-21-005012 |